Estrogens, Conjugated: Side Effects, Uses & Monitoring
PREMARIN therapy is indicated in the: Treatment of moderate to severe vasomotor symptoms due to menopause.
- Data source
- FDA labeling via NIH DailyMed (label b32fcb1b…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
PREMARIN therapy is indicated in the: Treatment of moderate to severe vasomotor symptoms due to menopause. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. Treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure. Treatment of breast cancer (for palliation only) in appropriately selected women and men with metastatic disease. Treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only). Prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and for whom non-estrogen medications are not considered to be appropriate. (See CLINICAL STUDIES .) The mainstays for decreasing the risk of postmenopausal osteoporosis are weight-bearing exercise, adequate calcium and vitamin D intake, and when indicated, pharmacologic therapy. Postmenopausal women require an average of 1500 mg/day of elemental calcium. Therefore, when not con…
Conditions associated with Estrogens, Conjugated in labeling
Breast Cancer
Cancer that forms in breast tissue. Early detection through screening improves outcomes....
Menopause
The natural end of menstrual periods and reproductive years, causing hot flashes, night sweats, and hormonal c...
Osteoporosis
A condition of weakened bones that increases the risk of fractures, often without symptoms until a fracture oc...
Frequently Asked Questions
What is Estrogens, Conjugated used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Estrogens, Conjugated?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Estrogens, Conjugated require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Estrogens, Conjugated.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.